David Johnson
2020 - Global Blood Therapeutics
Compensation breakdown
Non-Equity Incentive Plan | $234,000 |
---|---|
Option Awards | $1,582,504 |
Salary | $463,750 |
Stock Awards | $4,037,361 |
Other | $5,000 |
Total | $6,322,615 |
Johnson received $4M in stock awards, accounting for 64% of the total pay in 2020.
Johnson also received $234K in non-equity incentive plan, $1.6M in option awards, $463.8K in salary and $5K in other compensation.
Rankings
In 2020, David Johnson's compensation ranked 1,625th out of 13,090 executives tracked by ExecPay. In other words, Johnson earned more than 87.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,625 | 88th |
Manufacturing | 614 | 89th |
Chemicals And Allied Products | 220 | 90th |
Drugs | 183 | 91st |
Pharmaceutical Preparations | 128 | 91st |
Pay ratio
David Johnson's Pay | $6,322,615 |
---|---|
Median Employee's Pay | $373,366 |
Pay Ratio | 17to 1 |
In 2020, the annual total compensation of David Johnson was $6,322,615.
The annual total compensation of the median employee at Global Blood Therapeutics was $373,366.
The ratio of David Johnson's pay to the pay of median employee was therefore 17 to one.
Johnson's colleagues
We found four more compensation records of executives who worked with David Johnson at Global Blood Therapeutics in 2020.